pre-COPD的可治疗特征:将可治疗特征范式扩展到已确立疾病之外正当其时
本文为专家综述,提出应将可治疗特征(TTs)方法应用于临床诊断前的pre-COPD阶段。pre-COPD指有呼吸道症状和/或结构或功能异常但无气流受限的患者,其已存在可治疗的特征。综述结合终身肺功能轨迹与GETomics框架,讨论pre-COPD潜在TTs的现有证据并提出实践与研究建议。
要点
- pre-COPD为有症状和/或结构功能异常但无气流受限者,已存在可治疗特征。
- TTs方法应提前至临床诊断前,以预防COPD完全发病。
- GETomics强调基因与环境终身交互,整合多组学理解病因机制。
核心结论
- 在pre-COPD阶段识别并干预可治疗特征,可能有助于预防COPD完全发病。
- 将TTs引入pre-COPD可为健康与疾病的预防策略注入新动力。
研究设计与样本
- 专家综述,未报告系统检索范围与样本量。
- 讨论终身肺功能轨迹与GETomics框架对pre-COPD领域的贡献。
主要发现
- pre-COPD患者可能随时间出现气流受限,但已具有可治疗的特征。
- GETomics是基因与环境终身交互的动态累积模型,整合多组学信息理解疾病病因与机制。
关键数值与推荐
- pre-COPD定义为有呼吸道症状和/或结构或功能异常但无气流受限。
临床怎么用
- 对pre-COPD患者评估并处理已存在的可治疗特征。
- 将TTs方法用于临床诊断前阶段,以支持预防性干预。
局限性
- 为专家综述,未报告系统检索策略与纳入研究数量。
- pre-COPD潜在TTs的现有证据有限,需未来研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To date, the treatable traits (TTs) approach has been applied in the context of managing diagnosed diseases. TTs are clinical characteristics and risk factors that can be identified clinically and/or biologically, and that merit treatment if present. There has been an exponential increase in the uptake of this approach by both researchers and clinicians. Realizing the potential of the TTs approach to pre-clinical disease, this expert review proposes that it is timely to consider acting on TTs present before a clinical diagnosis is made, which might help to prevent development of the full disease. Such an approach is ideal for diseases where there is a long pre-clinical phase, such as in chronic obstructive pulmonary disease (COPD). The term 'pre-COPD' has been recently proposed to identify patients with respiratory symptoms and/or structural or functional abnormalities without airflow limitation. They may eventually develop airflow limitation with time but patients with pre-COPD are likely to have traits that are already treatable. This review first outlines the contribution of recently generated knowledge into lifetime lung function trajectories and the conceptual framework of 'GETomics' to the field of pre-COPD. GETomics is a dynamic and cumulative model of interactions between genes and the environment throughout the lifetime that integrates information from multi-omics to understand aetiology and mechanisms of diseases. This review then discusses the current evidence on potential TTs in pre-COPD patients and makes recommendations for practice and future research. At a broader level, this review proposes that introducing the TTs in pre-COPD may help reenergize the preventive approaches to health and diseases.
引用
- Dharmage SC, Faner R, Agustí A, et al. Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease. Respirology. 2024. PMID: 38862131. doi:10.1111/resp.14760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。